Biotalys
VUB

Biotalys

Biotech
Biotech
Biotech
Biotech

Biotalys is developing a new generation of protein-based biocontrol solutions. Euronext: BTLS.

Biotalys develops innovative formulations of crop protection products based on Agrobodies (antibody fragments from camel antibodies). These products can be used at lower dosages or have a longer lasting effect without repeat applications and thereby contribute to improved and more sustainable agricultural production. The company is a spin-off of the Vrije Universiteit Brussel and VIB.

No items found.
Marc Zabeau

Marc Zabeau

Managing Partner Qbic I

This company is aligned with the following SDGs

No items found.
Animab
Qbic III
Biotech
Biotech
Biotech
Biotech

Animab

Animab develops antibodies to tackle gastrointestinal pathogens in livestock.

Universiteit Gent
VUB
Spica Therapeutics
Qbic III
Biotech
Biotech
Biotech
Biotech

Spica Therapeutics

Spica Therapeutics is pioneering Macrophage-Subset targeted therapies

VUB
Flindr Therapeutics
Qbic III
Biotech
Biotech
Biotech
Biotech

Flindr Therapeutics

Flindr aims to restore a patient’s impaired immune response to cancer

Universiteit Gent